Korean drugmakers eye growth through OTC products

Published: 2009-03-20 06:59:00

Updated: 2009-03-20 06:59:00

With the government’s plan to allow supermarkets to sell OTC products in the near future, Korean pharmaceutical firms set about shaking up their existing organizations and paving the way for its future.

They aim to secure new revenue sources by developing more profitable OTC products.

“Ther...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK